The startup develops microbial-based biopharmaceutical products aimed at treating immune diseases, metabolic disorders, aging-related conditions, and cancer. Their formulations enhance patient recovery times and improve overall quality of life through targeted therapeutic interventions.
Funding
$22.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many diseases, including immune disorders, metabolic syndromes, aging-related conditions, and cancer, present significant challenges in treatment and management, often leading to prolonged recovery times and diminished quality of life for patients. Current therapeutic interventions may lack the specificity needed to target the underlying causes of these conditions effectively.
Solution
This startup is developing a range of microbial-based biopharmaceutical products designed to address immune diseases, metabolic disorders, aging-related conditions, and cancer. Their approach leverages the unique properties of microbial organisms to create targeted therapies that aim to enhance patient recovery and improve overall well-being. By harnessing the power of the microbiome, they seek to develop innovative treatments that offer more precise and effective interventions for these complex health challenges. The company's formulations are designed to modulate the body's natural processes, promoting healing and restoring balance.
Target Audience
The primary target audience includes individuals suffering from immune diseases, metabolic disorders, aging-related conditions, and cancer, as well as healthcare providers seeking innovative treatment options for these conditions.
Features
- Microbial-based formulations for targeted therapeutic interventions.
- Focus on immune diseases, metabolic disorders, aging-related conditions, and cancer.
- Designed to enhance patient recovery times.
- Aims to improve overall quality of life.